ArticleMolecular oncology2024

Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLC.

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.